{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:34:30Z","timestamp":1790674470192,"version":"4.1.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.juro.2013.06.012","type":"journal-article","created":{"date-parts":[[2013,6,11]],"date-time":"2013-06-11T15:46:35Z","timestamp":1370965595000},"page":"1990-1998","source":"Crossref","is-referenced-by-count":82,"title":["Germline PTEN Mutation Cowden Syndrome: An Underappreciated Form of Hereditary Kidney Cancer"],"prefix":"10.1097","volume":"190","author":[{"given":"Brian","family":"Shuch","sequence":"first","affiliation":[{"name":"Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Ricketts","sequence":"additional","affiliation":[{"name":"Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathy D.","family":"Vocke","sequence":"additional","affiliation":[{"name":"Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takefumi","family":"Komiya","sequence":"additional","affiliation":[{"name":"Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay A.","family":"Middelton","sequence":"additional","affiliation":[{"name":"Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric C.","family":"Kauffman","sequence":"additional","affiliation":[{"name":"Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria J.","family":"Merino","sequence":"additional","affiliation":[{"name":"Translational Surgical Pathology, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam R.","family":"Metwalli","sequence":"additional","affiliation":[{"name":"Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip","family":"Dennis","sequence":"additional","affiliation":[{"name":"Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Marston","family":"Linehan","sequence":"additional","affiliation":[{"name":"Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2013.06.012_bib1","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nrurol.2010.47","article-title":"The genetic basis of kidney cancer: a metabolic disease","volume":"7","author":"Linehan","year":"2010","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.juro.2013.06.012_bib2","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1101\/gr.131110.111","article-title":"Genetic basis of kidney cancer: role of genomics for the development of disease-based therapeutics","volume":"22","author":"Linehan","year":"2012","journal-title":"Genome Res"},{"key":"10.1016\/j.juro.2013.06.012_bib3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1086\/381054","article-title":"Early-onset renal cell carcinoma as a novel extraparaganglial component of SDHB-associated heritable paraganglioma","volume":"74","author":"Vanharanta","year":"2004","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.juro.2013.06.012_bib4","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1093\/jnci\/djn254","article-title":"Germline SDHB mutations and familial renal cell carcinoma","volume":"100","author":"Ricketts","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.juro.2013.06.012_bib5","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nature10539","article-title":"A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma","volume":"480","author":"Bertolotto","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.juro.2013.06.012_bib6","doi-asserted-by":"crossref","first-page":"136","DOI":"10.7326\/0003-4819-58-1-136","article-title":"Cowden\u2019s disease. A possible new symptom complex with multiple system involvement","volume":"58","author":"Lloyd","year":"1963","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.juro.2013.06.012_bib7","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/sj.ejhg.5200289","article-title":"Novel PTEN mutations in patients with Cowden disease: absence of clear genotype-phenotype correlations","volume":"7","author":"Nelen","year":"1999","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.juro.2013.06.012_bib8","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1086\/301639","article-title":"Inherited mutations in PTEN that are associated with breast cancer, cowden disease, and juvenile polyposis","volume":"61","author":"Lynch","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.juro.2013.06.012_bib9","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1136\/jmg.2004.018036","article-title":"Will the real Cowden syndrome please stand up (again)? Expanding mutational and clinical spectra of the PTEN hamartoma tumour syndrome","volume":"41","author":"Pilarski","year":"2004","journal-title":"J Med Genet"},{"key":"10.1016\/j.juro.2013.06.012_bib10","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.urology.2011.12.025","article-title":"Papillary renal cell carcinoma is associated with PTEN hamartoma tumor syndrome","volume":"79","author":"Mester","year":"2012","journal-title":"Urology"},{"key":"10.1016\/j.juro.2013.06.012_bib11","series-title":"Pathology and Genetics","author":"Eble","year":"2004"},{"key":"10.1016\/j.juro.2013.06.012_bib12","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/ijc.10513","article-title":"A population-based familial aggregation analysis indicates genetic contribution in a majority of renal cell carcinomas","volume":"100","author":"Gudbjartsson","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/j.juro.2013.06.012_bib13","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/gim.2012.51","article-title":"Estimate of de novo mutation frequency in probands with PTEN hamartoma tumor syndrome","volume":"14","author":"Mester","year":"2012","journal-title":"Genet Med"},{"key":"10.1016\/j.juro.2013.06.012_bib14","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ajhg.2010.11.013","article-title":"A clinical scoring system for selection of patients for PTEN mutation testing is proposed on the basis of a prospective study of 3042 probands","volume":"88","author":"Tan","year":"2011","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.juro.2013.06.012_bib15","first-page":"1719","article-title":"Two North American families with hereditary papillary renal\u00a0carcinoma and identical novel mutations in the MET proto-oncogene","volume":"58","author":"Schmidt","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.juro.2013.06.012_bib16","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.cell.2008.04.013","article-title":"Tenets of PTEN tumor suppression","volume":"133","author":"Salmena","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.juro.2013.06.012_bib17","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1097\/00000478-200212000-00002","article-title":"Renal tumors in the Birt-Hogg-Dube syndrome","volume":"26","author":"Pavlovich","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.juro.2013.06.012_bib18","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMra055323","article-title":"The tuberous sclerosis complex","volume":"355","author":"Crino","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.juro.2013.06.012_bib19","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1097\/PAS.0b013e318227e7f4","article-title":"Renal tumors associated with germline SDHB mutation show distinctive morphology","volume":"35","author":"Gill","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.juro.2013.06.012_bib20","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1097\/PAS.0b013e31804375b8","article-title":"The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome","volume":"31","author":"Merino","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.juro.2013.06.012_bib21","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/j.juro.2012.08.030","article-title":"Succinate dehydrogenase kidney cancer: an aggressive example of the warburg effect in cancer","volume":"188","author":"Ricketts","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2013.06.012_bib22","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1093\/jnci\/dji154","article-title":"High frequency of somatic frameshift BHD gene mutations in Birt-Hogg-Dube-associated renal tumors","volume":"97","author":"Vocke","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.juro.2013.06.012_bib23","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.cancergencyto.2007.10.010","article-title":"The UOK 257 cell line: a novel model for studies of\u00a0the human Birt-Hogg-Dube gene pathway","volume":"180","author":"Yang","year":"2008","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.juro.2013.06.012_bib24","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s10456-010-9164-2","article-title":"VHL and PTEN loss coordinate to promote mouse liver vascular lesions","volume":"13","author":"Chen","year":"2010","journal-title":"Angiogenesis"},{"key":"10.1016\/j.juro.2013.06.012_bib25","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1038\/emboj.2008.96","article-title":"pVHL and PTEN tumour suppressor proteins cooperatively suppress kidney cyst formation","volume":"27","author":"Frew","year":"2008","journal-title":"EMBO J"},{"key":"10.1016\/j.juro.2013.06.012_bib26","doi-asserted-by":"crossref","first-page":"17773","DOI":"10.1073\/pnas.1110969108","article-title":"Mutation of a single allele of the cancer susceptibility gene BRCA1 leads to genomic instability in human breast epithelial cells","volume":"108","author":"Konishi","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.juro.2013.06.012_bib27","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/cncr.25402","article-title":"The mammalian target of rapamycin pathway is widely activated without PTEN deletion in renal\u00a0cell carcinoma metastases","volume":"117","author":"Abou","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.juro.2013.06.012_bib28","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3816\/CGC.2007.n.020","article-title":"Potential histologic and molecular predictors of response to temsirolimus in patients with advanced renal\u00a0cell carcinoma","volume":"5","author":"Cho","year":"2007","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.juro.2013.06.012_bib29","doi-asserted-by":"crossref","first-page":"7066","DOI":"10.1158\/0008-5472.CAN-08-0922","article-title":"Chemoprevention and treatment of experimental Cowden\u2019s disease by mTOR inhibition with rapamycin","volume":"68","author":"Squarize","year":"2008","journal-title":"Cancer Res"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534713045825?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534713045825?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2013.06.012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T03:32:14Z","timestamp":1651203134000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2013.06.012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["10.1016\/j.juro.2013.06.012"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2013.06.012","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12]]}}}